2011•中国药理学报：英文版Requires access

The inhibition of lipoprotein-associated phospholipase A2 exerts beneficial effects against atherosclerosis in LDLR-deficient mice

Miaomiao, Hu, Jie Jie, Zhang, Wenyi, Wang, Wenyu, Wu, Yanling, M. A, Wei-hai, Chen, Yiping

Open publisher page 0 citations

Abstract

瞄准: 调查 darapladib 的效果，联系脂蛋白的 phospholipase A2 (lp-PLA2 ) 的一个特定的禁止者，在在低密度脂蛋白受体(LDLR ) 的发炎和动脉粥样硬化患者形成上缺乏的老鼠。

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: LDL receptor, Lipoprotein-associated phospholipase A2, Chemistry, Internal medicine, Endocrinology, Lipoprotein, Phospholipase A2, Cholesterol